Denfivontinib Hydrochloride

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameDenfivontinib Hydrochloride
Drug Alias NameDenfivontinibG-801SKI-G-801G-749 Hydrochloride
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsAXL receptor tyrosine kinase inhibitors
TargetsTyrosine-protein kinase receptor FLT3AXL receptor tyrosine kinase
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenosco
China Registration ClassN/A

Develop Information

Active CompaniesYatiri Bio IncOscotec Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A